Press Releases on May 8, 2024 - EIN Presswire - Press Release Distribution Service

Published on May 8, 2024 - 20:05 GMT

LifeMD Reports First Quarter 2024 Results; Raises Full Year Revenue Guidance

First quarter revenue increased 33% year-over-year to $44.1 million with telehealth revenue growing 53% versus the year-ago period. Raising full-year revenue guidance to at least $205 million, up from prior guidance of at least $200 million. Growth in all …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on May 8, 2024 - 20:05 GMT

ACV’s Data-Driven Solutions Drive Profits and Optimize Inventory for Dealerships

BUFFALO, N.Y., May 08, 2024 (GLOBE NEWSWIRE) -- ACV (Nasdaq: ACVA), the leading digital automotive marketplace and data services partner for dealers and commercial clients, is delivering innovative solutions to more dealers across the country who are …

Distribution channels: Automotive Industry, Media, Advertising & PR ...

Published on May 8, 2024 - 20:05 GMT

Leslie’s, Inc. Announces Second Quarter Fiscal 2024 Financial Results

Sales of $188.7 million Net Loss of $34.6 million Adjusted EBITDA of $(19.3) million Diluted earnings per share of $(0.19); Adjusted diluted earnings per share of $(0.17) Company reaffirms fiscal 2024 outlook PHOENIX, May 08, 2024 (GLOBE NEWSWIRE) -- …

Distribution channels:

Published on May 8, 2024 - 20:05 GMT

red violet Announces First Quarter 2024 Financial Results

BOCA RATON, Fla., May 08, 2024 (GLOBE NEWSWIRE) -- Red Violet, Inc. (NASDAQ: RDVT), a leading analytics and information solutions provider, today announced financial results for the quarter ended March 31, 2024. “We started 2024 by delivering record sales …

Distribution channels:

Published on May 8, 2024 - 20:05 GMT

LiveRamp to Discuss Fourth Quarter and Fiscal Year Results

SAN FRANCISCO, May 08, 2024 (GLOBE NEWSWIRE) -- LiveRamp® (NYSE: RAMP), the leading global data collaboration platform, today announced that its fiscal 2024 fourth quarter and full year earnings release will be issued on Wednesday, May 22, 2024 after the …

Distribution channels: Culture, Society & Lifestyle, Technology ...

Published on May 8, 2024 - 20:05 GMT

Lulus Reports First Quarter 2024 Results

Grew First Quarter 2024 Net Cash Provided by Operating Activities by 88%, $3.2 million from First Quarter 2023 Grew First Quarter 2024 Free Cash Flow by 127%, $3.4 million from First Quarter 2023 Board of Directors Authorized $2.5 million Share Repurchase …

Distribution channels: Business & Economy, Retail ...

Published on May 8, 2024 - 20:05 GMT

Jamf Releases First Quarter 2024 Financial Results

MINNEAPOLIS, May 08, 2024 (GLOBE NEWSWIRE) -- Jamf (NASDAQ: JAMF), the standard in managing and securing Apple at work, today announced financial results for its first quarter ended March 31, 2024, through an earnings release available on the company’s …

Distribution channels: Culture, Society & Lifestyle, Technology ...

Published on May 8, 2024 - 20:05 GMT

ZimVie Reports First Quarter 2024 Financial Results

Third Party Net Sales from Continuing Operations of $118.2 million Net Loss from Continuing Operations of ($11.5) million; Net Loss margin of (9.7%) Adjusted EBITDA[1] from Continuing Operations of $12.5 million; Adjusted EBITDA[1] margin of 10.5% …

Distribution channels:

Published on May 8, 2024 - 20:05 GMT

ACV Announces First Quarter 2024 Results

Delivered 22% Revenue Growth Revenue and Adjusted EBITDA at the High-End of Guidance First quarter revenue of $146 million First quarter GAAP net income (loss) of ($20) million First quarter non-GAAP net income of $1 million First quarter Adjusted EBITDA …

Distribution channels: Automotive Industry, Business & Economy ...

Published on May 8, 2024 - 20:05 GMT

Sana Biotechnology Reports First Quarter 2024 Financial Results and Business Updates

Goal to treat 40-60 patients in 2024 in four trials across seven indications in oncology, B-cell mediated autoimmune diseases, and type 1 diabetes Ongoing ARDENT trial for SC291 continues in B-cell malignancies; expect to report additional data in 2024 …

Distribution channels:

Published on May 8, 2024 - 20:05 GMT

SuRo Capital Corp. Reports First Quarter 2024 Financial Results

Net Asset Value of $7.17 Per Share as of March 31, 2024 Completed $35 Million in New Investments Year-to-Date NEW YORK, May 08, 2024 (GLOBE NEWSWIRE) -- SuRo Capital Corp. (“SuRo Capital”, the “Company”, “we”, “us”, and “our”) (Nasdaq: SSSS) today …

Distribution channels:

Published on May 8, 2024 - 20:05 GMT

Iridex to Report First Quarter 2024 Financial Results on May 14, 2024

MOUNTAIN VIEW, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on May 8, 2024 - 20:05 GMT

Vaxcyte Reports First Quarter 2024 Financial Results and Provides Business Update

-- VAX-31 Adult Phase 1/2 Study Enrollment Completed; Topline Safety, Tolerability and Immunogenicity Data Expected in Third Quarter of 2024 -- -- Following VAX-31 Adult Phase 1/2 Study Readout, Vaxcyte to Advance VAX-24 or VAX-31 to Adult Phase 3 Program …

Distribution channels:

Published on May 8, 2024 - 20:05 GMT

Lesaka Q3 2024 Results: Lesaka continues to deliver improved profitability

JOHANNESBURG, South Africa, May 08, 2024 (GLOBE NEWSWIRE) -- Lesaka Technologies, Inc. (Nasdaq: LSAK; JSE: LSK) today released results for the third quarter ended March 31, 2024 (“Q3 2024”). Performance Highlights for Q3 2024: Revenue of $138.2 million ( …

Distribution channels: Business & Economy, Electronics Industry ...

Published on May 8, 2024 - 20:05 GMT

Crinetics Pharmaceuticals to Present Advancements from Atumelnant (CRN04894) and Paltusotine Development Programs at ENDO 2024

Initial Data from Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia to be Presented, Along with Initial Findings from Phase 1b/2a ACTH-Dependent Cushing’s Syndrome Trial Data from Phase 3 PATHFNDR 1 and 2 Trials of Paltusotine in Acromegaly …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on May 8, 2024 - 20:05 GMT

OraSure Reports Q1 ’24 Revenue of $54.1 Million

Q1 GAAP EPS of $(0.05); Q1 Non-GAAP EPS of $0.04 Restructuring initiatives expected to result in $15 million of annualized expense reductions once fully implemented and position OraSure to achieve cash flow breakeven for core business by end of 2024 …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on May 8, 2024 - 20:05 GMT

PetIQ, Inc. Reports First Quarter 2024 Financial Results

Reports Record First Quarter 2024 Net Sales of $308.4 Million Achieves Record First Quarter Net Income Record Adjusted EBITDA Exceeds Company's First Quarter 2024 Guidance Raises Full Year 2024 Outlook EAGLE, Idaho, May 08, 2024 (GLOBE NEWSWIRE) -- …

Distribution channels:

Published on May 8, 2024 - 20:05 GMT

RadNet Reports First Quarter Financial Results with Record First Quarter Revenue, Adjusted EBITDA(1) and Adjusted Earnings(3) and ...

Total Company Revenue increased 10.5% to $431.7 million in the first quarter of 2024 from $390.6 million in the first quarter of 2023; Revenue from the Digital Health reportable segment increased 32.3% to $14.7 million in the first quarter of 2024 from $11 …

Distribution channels:

Published on May 8, 2024 - 20:05 GMT

Allbirds Reports First Quarter 2024 Financial Results

Achieves Q1 2024 Financial Guidance Continues to Advance its Strategic Transformation Plan Reiterates Full Year 2024 Outlook; Provides Q2 2024 Guidance SAN FRANCISCO, May 08, 2024 (GLOBE NEWSWIRE) -- Allbirds, Inc. (NASDAQ: BIRD), a global lifestyle brand …

Distribution channels:

Published on May 8, 2024 - 20:05 GMT

Magnite Reports First Quarter 2024 Results

Total Revenue Grows 15% & Contribution ex-TAC(1) Grows 12% Year-Over-Year Contribution ex-TAC(1) from CTV Grows 18% Year-Over-Year NEW YORK, May 08, 2024 (GLOBE NEWSWIRE) -- Magnite (NASDAQ: MGNI), the world's largest independent sell-side …

Distribution channels: Business & Economy, Technology ...